Q3 2009
Metabolix Awarded US Department of Agriculture Grant to Develop Biobased, Biodegradable Bottles
Q2 2009
Metabolix Announces That Mirel(TM) Bioplastic Has Been Certified Compostable by the Biodegradable Products Institute
Q2 2009
Metabolix Announces that Mirel(TM) Bioplastic Resins Have Received Vinçotte Certification for Biodegradability in Industrial and Home Compost
Q4 2008
Metabolix Co-Founder Oliver P. Peoples Receives 2008 Personal Contribution to Bioplastics Award
Q4 2008
Metabolix Announces that Mirel™ Bioplastic Resins are Vinçotte Certified to European Soil and Fresh Water Biodegradability Standards
Q3 2008
Metabolix Demonstrates Viability of Bioplastic Production in Switchgrass Plants
Q1 2008
Metabolix establishes a strategic research collaboration with noted oilseed experts at the Donald Danforth Plant Science Center to Develop advanced industrial oilseed crops for bioplastic and biofuel production
Q2 2007
Metabolix signs an agreement with Australia's Cooperative Research Centre for Sugar Industry Innovation to research and develop bioplastics in sugarcane.
Q2 2007
Metabolix and ADM name their joint venture Telles
Q4 2006
Metabolix wins ICIS award
Q4 2006
Metabolix completes its IPO
Q1 2006
Metabolix wins SPE GPEC Award for new technology in renewable materials and processes
Q1 2006
Metabolix and ADM announce site selection for first commercial plant for production of bioplastics
Q1 2006
Metabolix begins pilot plant production of PHAs
Q2 2005
Metabolix wins 2005 Presidential Green Chemistry Challenge Award
Q4 2004
Metabolix forms strategic alliance with ADM to commercialize bioplastics via fermentation
Q3 2003
Dept. of Commerce Awards Metabolix $1.6 million to develop highly efficient PHA production bacteria
Q1 2002
Metabolix demonstrates high yield commercial scale manufacture of PHA, validates cost projections
Q3 2001
Metabolix demonstrates scalable, high-yield copolymer production at pilot scale
Q3 2001
Metabolix awarded $15 million DOE Biomass Biorefinery Project
Q2 2001
Metabolix acquires BiopolTM assets from Monsanto
Q1 2000
Metabolix demonstrates high yield PHA production at laboratory scale
1998
Metabolix establishes plant program
1994 – 2000
Metabolix develops microbial production platform for PHA
-high productivity/low cost
-broad compositional control
1994
Metabolix establishes laboratory in Cambridge, MA
1993
Metabolix licenses basic technology from MIT
1992
Metabolix incorporated
BACK TO TOP
